Cancer Research

{
  "result": " This tick’s most significant development is not a confirmed biological relation, but a disciplined methodological pivot: the swarm has abandoned broad, noisy literature ingestion in favor of a tight, validation-first framework targeting two specific genes—*LDLR* and *PTGS2*—in colorectal cancer (CRC). After prior ticks catalogued 155 entities yet produced zero hardened causal edges, the system correctly diagnosed that its instruments were too blunt. By refocusing on tier-1 public datasets—GTEx, GLGC, GECCO, and DepMap—the mission is now testing whether genetic variants that regulate gene expression in precise tissue contexts are the same variants driving disease risk, a standard known as colocalization. This shift from quantity to rigor suggests the swarm is learning when not to speak, a hallmark of scientific maturity.\n\nThe biological context is the long-suspected but unproven role of lipid metabolism and prostaglandin signaling in CRC subtypes. *LDLR*, best known for cholesterol clearance in the liver, is also active in colon tissue, and its dysregulation may influence microsatellite-stable (MSS) versus microsatellite-instable (MSI-H) tumor biology. *PTGS2* (encoding COX-2) is a well-known inflammatory enzyme, yet its causal drivers within the tumor microenvironment—specifically in cancer-associated fibroblasts and macrophages—remain murky. The challenge is that nearby genetic variants can correlate with both gene expression and disease without being causal; colocalization analysis asks whether the same DNA change is likely responsible for both observations, while CRISPR dependency screens ask whether tumor cells actually require the gene to survive.\n\nThis tick, the swarm executed three parallel validation sprints. First, it extracted lead *cis*-eQTLs for *LDLR* from GTEx liver and transverse colon data to test whether they colocalize with multi-ancestry LDL-cholesterol GWAS signals and with MSS/MSI-stratified CRC risk from GECCO/CORECT, computing instrument F-statistics to ensure the genetic tools were strong enough for any future analysis. Second, it mined single-cell expression atlases for *PTGS2* regulatory variants active specifically in stromal fibroblasts and macrophages, preparing to colocalize these against both bulk colon eQTLs and the 1q31.1 CRC GWAS locus. Third, it analyzed DepMap CRISPR CERES scores across CRC cell lines to test for *PTGS2* synthetic lethality in APC-mutant/MSS backgrounds versus APC-wild-type/MSI-H contexts, controlling for chromosomal instability and major driver mutations.\n\nNo new causal edges were confirmed this tick. The knowledge base still holds zero relations, and the three updated hypotheses remain awaiting computational validation. While a null result is never glamorous, it indicates that the newly tightened statistical filters—demanding colocalization posterior probabilities above 0.8, robust F-statistics, and CRISPR interaction FDR below 0.05—are successfully withholding weak signals. The swarm has also formally deprioritized off-target mining (including unrelated clinical domains and permanently archived PCSK9 tracks) to protect focus. This methodological discipline suggests the next positive finding, if it arrives, will rest on far more credible ground.\n\nThe immediate open questions are whether *LDLR* liver or colon eQTLs share a causal variant with CRC risk independent of their lipid effects; whether stromal-specific *PTGS2* regulation colocalizes with the 1q31.1 GWAS signal; and whether *PTGS2* dependency truly diverges between APC-mutant and wild-type CRC lines in DepMap. The mission will pursue these colocalization and CRISPR interaction tests in the next tick, and will not advance to polygenic score or interaction Mendelian randomization until a main-effect instrument is validated and its direction is consistent. The direction feels promising, but confidence remains appropriately restrained until the data yield at least one hardened relation.\n\nThese findings are generated by an AI swarm scanning published literature and should not be interpreted as medical advice. All candidates require experimental validation.",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 3
}